The Process of Small Volume Parenterals Manufacturing

Getting your small volume parenterals manufacturing process up and running is no joke. As with any other pharmaceutical manufacturing process, the sanitary standards here are extremely high. But the risk involved in parenterals is even greater since they directly enter the bloodstream, tissues or organs, making it even more important to ensure the process is aseptic all through.

What are Parenterals?

First things first: what are parenterals? Parenterals are any pharmaceutical preparations that are meant to be delivered into the body through the skin or other external boundary tissue. By delivering active ingredients directly into the bloodstream or body tissue, the alimentary canal is bypassed entirely.

Parenterals are sterile and pyrogen-free preparations, in either liquid or solid form, which may be delivered via subcutaneous, intramuscular or intravenous injection. They may also be injected directly into more specialised tissue like the spinal cord, or be delivered by other means through external body tissue, for instance, ophthalmic preparations that can be dropped directly into the eyes.

Parenterals are divided into two main categories: small volume parenterals (SVPs) and large volume parenterals (LVPs).

What are Small Volume Parenterals (SVPs)?

Small volume parenterals refers to pharmaceutical preparations which are packaged in containers of 100 ml or less. This usually includes preparations packaged in vials, ampoules, pre-filled syringes and even squeezable containers meant for injection or topical application, with doses generally ranging from 1 ml to 30 ml, packaged either as single or multiple doses.

Large volume parenterals, on the other hand, are packaged in containers greater than 100 ml in volume. Generally, they are meant for intravenous use and are available in volumes ranging from 100 ml to 1000 ml, mostly as a single dose.

Features, Types & Applications of Small Volume Parenterals

As mentioned above, small volume parenterals differ in features from large volume parenterals in volume, number of doses, and delivery method.

According to their purpose, different types of small volume parenterals are packaged differently. You may find small volume parenterals in ampoules, vials, pre-filled syringes, cartridges, bottles or any other container that matches the volume and sterility requirements of SVPs. Other SVPs like eye drops which are applied topically may also be available in squeezable plastic containers.

Further, small volume parenterals are produced in two forms – either liquid or dry powder preparations, depending on the stability of the pharmaceutical product in liquid form. Finally, types of small volume parenterals also differ by dose – you get either single dose or multiple dose parenterals.

Aspects Involved in Small Volume Parenterals Formulation: Staff, Sections, Equipment and Machinery

Pharmaceutical manufacturing is easily one of the most complex and stringently-monitored processes in the world. And with good reason, considering the direct implications of pharmaceutical drugs on the health and lives of the people who use them.

With parenterals and otherwise, it is becoming more and more important to produce products which are acceptable for world markets. With transnational supply chains and the global movement of pharmaceutical drugs, requirements are becoming more unified, the most largely prescribed being the United States, European, and Japanese Pharmacopoeias. Today, small volume parenterals processing requirements are based on current Good Manufacturing Practices (cGMP) guidelines, with strict controls ensuring that products meet the prescribed standards for sterility, particulate matter, microbial presence, pyrogens and other potential contaminants. Even the water used in the manufacture of different types of small volume parenterals is subject to strict standards and tests, with water for injection, purified water, and pure steam being generated under strictly controlled conditions.

All the different elements of small volume parenterals manufacturing include water for injection, solutes, active ingredients, antimicrobial agents, antioxidants and many more which are brought together under controlled conditions.

The workforce requirements of small volume parenterals manufacturing range from technical workers like manufacturing and analytical chemists, quality assurance professionals and production managers, to non-technical staff including machine operators and other individuals involved in supporting activities.

Even the sections of the plant, for both dry and liquid injection manufacturing, need to be separated as per the purpose they serve in the process. A high quality SVP manufacturer who is adamant on quality and insistent on preventing cross-contamination will have different sections for warehousing, sterile raw materials, washing, sterilisation, general production, mixing, filling, sealing, packaging and labelling.

These processes should occur either aseptically or the final product must be terminally sterilised, depending on the heat stability and other features of the final product. Either way, the equipment and vessels used for small volume parenteral manufacturing include storage equipment for vials, ampoules and closures, washing and drying equipment, process vessels for mixing and holding, filtration equipment, sterilisation machines, and bacteriological filters amongst many others.

Essential Aspects of the Manufacturing Process

No matter which specific types of small volume parenterals are being produced, there are some general steps and principles you should keep in mind to ensure the sterility of your process and the integrity of your final product.

For both dry injections and liquid parenteral preparations, dispensed raw materials, APIs and packaging materials should be held in aseptic areas. Vials, stoppers, caps and any other parts of the container which will come in contact with the pharmaceutical product must be washed, dried and sterilised using the appropriate methods. This may be sterilisation by moist heat, dry heat, radiation or any other industry-accepted technique. After the product is prepared by mixing the API(s) and other raw materials in a sterile manner and filled in the appropriate containers, the filling vials must be capped, sealed, labelled and packaged.

Ideally, there are some general principles which should guide the manufacturing process throughout the small volume parenterals’ production journey. To ensure only high quality and safe products leave your manufacturing facility, different types of small volume parenterals should only be released after complete filling and testing, with results of tests measuring sterility, pyrogens and bacterial endotoxins maintained in a systematic manner. Separately, even validation details and simulation trail records should be maintained. Importantly, data concerning environmental monitoring like temperature, humidity and microbial presence should also be kept available for future reference.

Quality Control

Ultimately, even after maintaining a highly sterile environment throughout the manufacturing process, there are a set of controls that must be implemented to make sure that the final product you deliver to your consumers reaches the highest safety and quality standards.

There are a number of tests that are implemented to make sure your small volume parenterals are free of contaminants and securely packaged. While the leaker’s test ensures that ampoules are properly sealed, the sterility test, clarity test and pyrogen test ensure that small volume parenterals containers are free of pyrogens and particulate contaminants.

At TSA, our range of large and small volume parenteral processing vessels meets the highest quality standards in the industry. Our manufacturing, compounding, holding and storage vessels can be customised to your product specifications in terms of not just insulation, level sensing and load cells, but can also match up to your maintenance regime with CIP and SIP integrations. If you haven’t checked them out yet, what are you waiting for?


You might find these interesting – 

Share this post:

For 20 years, we’ve been the go-to problem-solvers for high-purity and injectable process applications in the pharma and biopharma industry. We are relentless about continuous process improvement and upskilling, elevating ourselves and our technology so you can get the job done more efficiently with cost optimisations. Use the form below to schedule a call back from our team.

Name(Required)
This field is for validation purposes and should be left unchanged.

Hetal Panchal is the Vice President in Operations department of TSA Process Equipments (A Thermax Group Company) since 1 s t October 2012.

Holding a qualification in Production Engineering and 28 years of industry experience, he specializes in designing advanced equipment for the pharmaceutical sector. His expertise lies in optimizing production lines, improving efficiency, and ensuring compliance with regulatory standards.
Focused on innovation, he has developed systems that enhances productivity, minimizes downtime, and maintains product quality. Staying current with technological trends, they contribute to ongoing improvements in the industry.
His extensive experience has helped identify opportunities for innovation, streamlining operations and reducing costs. Through his specialized knowledge, more efficient manufacturing processes and higher-quality outputs in pharmaceutical production are delivered.

B.C. Mahesh is the Chairperson of TSA Process Equipment Pvt. Ltd. since Feb 2024.

B.C. Mahesh became a member of the Executive Council in August 2013. He is responsible for the Industrial Product Business (IPB), which consists of Process Heating, Absorption Cooling & Heating Solutions, Water and Waste Solutions, Air Pollution Control, Steam Engineering, Channel Business Group, International Business Group, and Enterprise Sales businesses.
As part of IPB, he also oversees the following wholly-owned subsidiaries
of Thermax – Danstoker, PT Thermax International Indonesia and Rifox.Mahesh joined Thermax as a graduate trainee in 1988 and handled the Materials function for various businesses, including global sourcing, till 1996.
He moved to the Power division(P&ES) and grew to the position of Sales Head and subsequently Head of Projects. He took over as the Head of the SBU for Medium Power Plants in 2009 and finally as Head of Power business in 2012.
Mahesh has worked with Thermax for over 30 years in many functions such as manufacturing, supply chain, sales and marketing, and project management, and has played a significant role in the strategy, expansion and diversification of the Power business.Mahesh completed his Mechanical Engineering from the Visvesvaraya Regional College of Engineering, Nagpur in 1988.

Vishal Mehra is the Director of TSA Process Equipment Pvt. Ltd. since Feb 2024.

Mr. Vishal Mehra is currently serving as the Strategic Business Unit Head for Water & Waste Solutions (WWS) at Thermax Limited. Additionally, he holds a directorial position at TSA Process Equipment, which is known for its expertise in ultra-pure and high-purity water technologies and was recently acquired by Thermax.With over 22 years of experience in the industry, Mr. Mehra’s professional focus includes water management solutions, advanced technology development, and business strategy.
His areas of interest encompass cutting-edge technology, growth strategies, organizational effectiveness, and development.
Mr. Mehra is well qualified in business management and strategy transformation, having completed the Senior Executive Program in Business Management and Strategy Transformation from London Business School. This advanced education supports his extensive experience and expertise in the field.

Sandeep Deshpande has been the Director of TSA Process Equipments Pvt. Ltd. since February 2024.

Currently, he serves as the Head of Corporate Finance and the Industrial Product Group at Thermax Limited. With over 21 years of experience in finance, he has developed expertise in financial consolidation, planning, reporting, costing, accounting, controlling and financial modeling.
Currently, he serves as the Head of Corporate Finance and the Industrial Product Group at Thermax Limited. With over 21 years of experience in finance, he has developed expertise in financial consolidation, planning, reporting, costing, accounting, controlling and financial modeling.
Sandeep is a qualified Cost Accountant Company Secretary, and holds a diploma in IFRS and an advanced diploma in financial management from XLRI. He has extensive experience in financial operations, including financial planning, MIS, budgeting, controlling, audits, and cash flow management. His expertise also spans financial reporting, consolidation, mergers and acquisitions, due diligence, business restructuring, and implementing Internal Financial Control (IFC) and Enterprise Risk Management (ERM). Additionally, Sandeep has hands-on experience with Oracle systems, automation, digitization, and business analytics. He is passionate about driving good governance, improving financial reporting, and leveraging automation and digitization to enhance business analytics.

Rajiv Parikh is the COO of TSA Process Equipments (A Thermax Group Company) since April 2024.

Rajiv is a highly accomplished professional with extensive experience in the pharmaceutical and FMCG sectors, specializing in high-purity and process vessels. He played a key role in establishing TSA Process Equipments Pvt. Ltd., driving its growth and success. His deep technical expertise, combined with a strong understanding of client needs, has enabled him to deliver innovative solutions to complex industry challenges.

Throughout his career, Rajiv has excelled in leadership and sales, consistently launching cutting-edge products that have positively impacted the market. His ability to build lasting client relationships and offer tailored solutions has earned him a reputation as a trusted industry leader.

With a background in Mechanical Engineering, Rajiv blends technical proficiency with strategic vision. His contributions have shaped industry standards and positioned him as a key influencer in the pharmaceutical and FMCG sectors.

Apurva Shah is the CEO of TSA Process Equipments (A Thermax Group Company) since April 2024.

With a career spanning over 24 years, Apurva is the visionary CEO of TSA Process Equipments, where he has led the company to new heights in the High Purity & process equipment industry. A graduate in Mechanical Engineering from Mumbai University, followed by an MBA in Business Management from NMIMS, He brings a strong technical foundation combined with a sharp strategic mindset.

His expertise lies in formulating and executing strategies that drive growth and operational efficiency. Over the years, he has cultivated a deep understanding of market dynamics, positioning TSA Process Equipments for continued success in a competitive landscape.

Outside of his professional pursuits. He is an avid reader, with a particular interest in fiction novels, which fuel his creativity and broaden his perspective.